Collegium Pharmaceutical Inc (COLL)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	166,961	117,030	92,484	67,961	33,319	-12,560	-18,878	-13,579	17,628	66,746	72,223	72,363	56,232	38,863	12,862	-8,695	-23,748	-10,374	-15,185	-17,470
Total assets	US$ in thousands	1,143,310	1,177,580	1,213,910	1,214,300	1,174,130	1,200,940	1,245,570	1,246,140	692,077	741,803	713,735	646,065	643,841	643,843	646,870	634,793	306,302	303,978	301,581	294,362
Operating ROA		14.60%	9.94%	7.62%	5.60%	2.84%	-1.05%	-1.52%	-1.09%	2.55%	9.00%	10.12%	11.20%	8.73%	6.04%	1.99%	-1.37%	-7.75%	-3.41%	-5.04%	-5.93%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $166,961K ÷ $1,143,310K
= 14.60%

Collegium Pharmaceutical Inc's operating return on assets (operating ROA) has shown consistent improvement over the past eight quarters. The operating ROA has increased from -1.15% in Q2 2022 to 14.60% in Q4 2023, indicating a significant turnaround in the company's operational efficiency and profitability. This upward trend suggests that Collegium Pharmaceutical Inc has been able to generate increasing operating income relative to its total assets, which is a positive sign for the company's financial health. Overall, the improving operating ROA reflects positively on Collegium Pharmaceutical Inc's ability to effectively utilize its assets to drive operational performance and create value for its stakeholders.